RecruitingNot ApplicableNCT03594344
Additional Hyperbaric Oxygen After Lower Extremity Amputation
Additional Hyperbaric Oxygen After Lower Extremity Amputation - A Randomized Controlled Trial
Sponsor
Oslo University Hospital
Enrollment
120 participants
Start Date
Jul 4, 2018
Study Type
INTERVENTIONAL
Conditions
Summary
This study evaluates the effect of additional hyperbaric oxygen therapy after lower extremity amputation. The patients will be randomized after amputation to either a treatment group receiving hyperbaric oxygen therapy, or control group.
Eligibility
Min Age: 18 YearsMax Age: 90 Years
Inclusion Criteria6
- Lower extremity amputation because of chronic wound, osteomyelitis, ischemia, necrosis.
- Fit to receive hyperbaric oxygen therapy determined by an anesthesiologist/Hyperbaric Medicine Physician.
- Able to cooperate and follow up appointments
- Included within 7 days after final surgery
- Pregnancy
- Dementia
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDUREHyperbaric oxygen therapy
Breathing 100% oxygen for 30+30+30 min at 2,4 ATA. in a multiplace hyperbaric chamber. Total of 30 sessions
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03594344
Related Trials
Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery
NCT070111472 locations
Family Investigation of Nephropathy and Diabetes (F.I.N.D.)
NCT003429271 location
Pioglitazone Versus Empagliflozin for Chronic Pancreatitis/Recurrent Acute Pancreatitis Associated Diabetes Mellitus
NCT067299962 locations
Early Tracking of Childhood Health Determinants (ETCHED) Study
NCT034818291 location
Prevalence of Diabetes-related Distress Among Patients Living With Type 2 Diabetes in a University Hospital Center and Identification of Its Associated Factors.
NCT073924371 location